Cite
Pires de Sousa MV, Ferraresi C, Kawakubo M, et al. Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate. Neurophotonics. 2016;3(1):015003doi: 10.1117/1.NPh.3.1.015003.
Pires de Sousa, M. V., Ferraresi, C., Kawakubo, M., Kaippert, B., Yoshimura, E. M., & Hamblin, M. R. (2016). Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate. Neurophotonics, 3(1), 015003. https://doi.org/10.1117/1.NPh.3.1.015003
Pires de Sousa, Marcelo Victor, et al. "Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate." Neurophotonics vol. 3,1 (2016): 015003. doi: https://doi.org/10.1117/1.NPh.3.1.015003
Pires de Sousa MV, Ferraresi C, Kawakubo M, Kaippert B, Yoshimura EM, Hamblin MR. Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate. Neurophotonics. 2016 Jan;3(1):015003. doi: 10.1117/1.NPh.3.1.015003. Epub 2016 Jan 25. PMID: 26835486; PMCID: PMC4725212.
Copy
Download .nbib